Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Orna Therapeutics is a biotechnology company pioneering the development of a new class of fully engineered circular RNA (oRNA™) therapies. Their proprietary platform aims to overcome the limitations of traditional linear mRNA by creating oRNA molecules with potentially greater stability, simplified production, and improved immunogenicity profiles. Orna is focused on advancing these therapies for a wide range of diseases, including cancer, genetic disorders, and infectious diseases, with an initial focus on in situ CAR (isCAR™) therapy for oncology.
The Cambridge headquarters serves as the central hub for Orna's research and development, corporate strategy, business development, and administrative operations.
Located within a modern life sciences complex, the facility likely includes state-of-the-art laboratory spaces for RNA research, cell biology, and preclinical development, alongside collaborative office environments.
The work culture is expected to be highly innovative, science-driven, and collaborative, characteristic of biotech companies in the competitive Cambridge ecosystem. There's likely a strong emphasis on cutting-edge research, problem-solving, and a fast-paced environment.
The Cambridge location provides Orna Therapeutics with unparalleled access to a rich ecosystem of academic institutions (like MIT and Harvard), skilled talent, venture capital, and potential collaborators, fostering innovation and growth.
Currently, Orna Therapeutics's primary operations are centered in its Cambridge, MA headquarters. While they may engage in global collaborations for research or clinical trials, they do not appear to have other major physical office locations publicly listed. Their therapeutic ambitions, however, are global, aiming to address diseases affecting patients worldwide.
200 Cambridgepark Drive, Suite 2000
Cambridge
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Orna Therapeutics' leadership includes:
Orna Therapeutics has been backed by several prominent investors over the years, including:
Orna Therapeutics has seen some key additions to its leadership team over the past year, strengthening its development and operational capabilities. No high-profile executive departures have been prominently reported.
Discover the tools Orna Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Orna Therapeutics likely uses common corporate email formats. Based on industry standards and company size, the most probable formats involve combinations of first name, last name, and initials.
Common formats include [first_initial][last]@ornatx.com (e.g., jdoe@ornatx.com) or [first].[last]@ornatx.com (e.g., jane.doe@ornatx.com).
Format
tebeling@ornatx.com
Example
80%
Success rate
Orna Therapeutics Website • February 7, 2024
Orna Therapeutics announced a publication in Nature Biotechnology detailing preclinical data that demonstrate the potential of its circular RNA (oRNA) based in situ CAR (isCAR) platform to generate and deliver CAR RNA therapeutics in vivo for the treatment of cancer....more
Orna Therapeutics Website • August 16, 2023
Orna Therapeutics announced the appointment of William J. Rote, Ph.D., as Chief Development Officer. Dr. Rote brings extensive experience in drug development to lead Orna's programs into clinical stages....more
PR Newswire • February 16, 2023
Orna Therapeutics announced the closing of a $221 million Series B financing round. The funding will be used to advance its platform and pipeline of oRNA-based therapeutics, including its lead isCAR program into clinical trials....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Orna Therapeutics, are just a search away.